Matzim LA

Product NDC: 52544-692
Requested package NDC: 52544-692-19
11-digit product format: 525440692
Labeler code: 52544
Product ID: 52544-692_fb6251e2-4e72-4fe6-9e4f-02baf57d97ca
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Diltiazem Hydrochloride
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Labeler: Actavis Pharma, Inc.
Application: ANDA077686
Marketing category: ANDA
Marketing start: 2011-03-28
Substance: DILTIAZEM HYDROCHLORIDE
Active strength: 240 mg/1
Pharmacologic classes: Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A077686-001	DILTIAZEM HYDROCHLORIDE	DILTIAZEM HYDROCHLORIDE	420MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15
A077686-002	DILTIAZEM HYDROCHLORIDE	DILTIAZEM HYDROCHLORIDE	360MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15
A077686-003	DILTIAZEM HYDROCHLORIDE	DILTIAZEM HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15
A077686-004	DILTIAZEM HYDROCHLORIDE	DILTIAZEM HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15
A077686-005	DILTIAZEM HYDROCHLORIDE	DILTIAZEM HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15
A077686-006	DILTIAZEM HYDROCHLORIDE	DILTIAZEM HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 6 matching rows.

Application-product, TE code table
Application-product	TE code
A077686-001	AB
A077686-002	AB
A077686-003	AB
A077686-004	AB
A077686-005	AB
A077686-006	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 7 · 258 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A077686-001	DILTIAZEM HYDROCHLORIDE	420MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077686-002	DILTIAZEM HYDROCHLORIDE	360MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077686-003	DILTIAZEM HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077686-004	DILTIAZEM HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077686-005	DILTIAZEM HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077686-006	DILTIAZEM HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077686-001	DILTIAZEM HYDROCHLORIDE	420MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077686-002	DILTIAZEM HYDROCHLORIDE	360MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077686-003	DILTIAZEM HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077686-004	DILTIAZEM HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077686-005	DILTIAZEM HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077686-006	DILTIAZEM HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077686-001	DILTIAZEM HYDROCHLORIDE	420MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077686-002	DILTIAZEM HYDROCHLORIDE	360MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077686-003	DILTIAZEM HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077686-004	DILTIAZEM HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077686-005	DILTIAZEM HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077686-006	DILTIAZEM HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077686-001	DILTIAZEM HYDROCHLORIDE	420MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077686-002	DILTIAZEM HYDROCHLORIDE	360MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077686-003	DILTIAZEM HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077686-004	DILTIAZEM HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077686-005	DILTIAZEM HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077686-006	DILTIAZEM HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077686-001	DILTIAZEM HYDROCHLORIDE	420MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077686-002	DILTIAZEM HYDROCHLORIDE	360MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077686-003	DILTIAZEM HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077686-004	DILTIAZEM HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077686-005	DILTIAZEM HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077686-006	DILTIAZEM HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077686-001	DILTIAZEM HYDROCHLORIDE	420MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077686-002	DILTIAZEM HYDROCHLORIDE	360MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077686-003	DILTIAZEM HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077686-004	DILTIAZEM HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077686-005	DILTIAZEM HYDROCHLORIDE	180MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077686-006	DILTIAZEM HYDROCHLORIDE	120MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077686-001	DILTIAZEM HYDROCHLORIDE	420MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077686-002	DILTIAZEM HYDROCHLORIDE	360MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077686-003	DILTIAZEM HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077686-004	DILTIAZEM HYDROCHLORIDE	240MG	TABLET, EXTENDED RELEASE / ORAL	AB	2010-03-15	`b8a1b40f171c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 7 · 258 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A077686-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077686-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077686-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077686-004	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077686-005	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077686-006	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077686-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077686-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077686-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077686-004	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077686-005	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077686-006	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077686-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077686-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077686-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077686-004	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077686-005	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077686-006	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077686-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077686-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077686-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077686-004	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077686-005	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077686-006	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077686-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077686-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077686-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077686-004	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077686-005	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077686-006	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077686-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077686-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077686-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077686-004	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077686-005	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077686-006	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077686-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077686-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077686-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077686-004	AB	1	`b8a1b40f171c…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Matzim LA
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DILTIAZEM HYDROCHLORIDE	240 mg/1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
61ebbccf-eedf-453b-940e-dba67b7a5fef	Product name	4	20260107
a8d6eaa3-afcc-47e5-be12-0c9251fc8740	Product name	1	20251124
f6700316-a6ba-5e59-3413-8ede05ae58b9	Product name	7	20250625
8615f7a1-1e8f-8281-8601-d7a637926d1f	Product name	4	20250522
3a9daa2f-bcd1-13de-a1b4-6172caa7f308	Product name	2	20240419
f7129636-cba8-86c2-8bfb-9e2e2a9c7628	Product name	2	20240314
378290be-e30f-0e68-1201-165e93c337e8	Product name	3	20231212
c733b56e-b0b5-4495-9857-0256a8242279	Product name	1	20220520
f4df4721-60d9-7fd2-a665-5c3c9f55af81	Product name	2	20171003

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
52544-692-10	Matzim LA	1000 in 1 BOTTLE, PLASTIC	TABLET, EXTENDED RELEASE	1000	13
52544-692-19	Matzim LA	90 in 1 BOTTLE, PLASTIC	TABLET, EXTENDED RELEASE	90	13
52544-692-30	Matzim LA	30 in 1 BOTTLE, PLASTIC	TABLET, EXTENDED RELEASE	30	13

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
52544-692-19	EA - Each	52544-692	c8b0a619-6eaa-4abb-ae06-e999214c8194	1	2012-07-24
52544-692-30	EA - Each	52544-692	8d1aef7d-8653-4234-8c6a-be3ebffbba7e	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DILTIAZEM HYDROCHLORIDE	ACTIVE INGREDIENT	OLH94387TE	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
DILTIAZEM	ACTIVE MOIETY	EE92BBP03H	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
CANDELILLA WAX	INACTIVE INGREDIENT	WL0328HX19	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
ETHYLCELLULOSES	INACTIVE INGREDIENT	7Z8S9VYZ4B	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
NONOXYNOL-100	INACTIVE INGREDIENT	A906T4D368	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
SUCROSE	INACTIVE INGREDIENT	C151H8M554	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
52544-692	MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]	10	Current NDC, Legacy NDC, 3 package rows	20250406_e8c8dd18-9d95-4068-9762-bec1eb1bc25c.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
OLH94387TE	DILTIAZEM HYDROCHLORIDE	33286-22-5	DILTIAZEM HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
830877	dilTIAZem hydrochloride 180 MG 24HR Extended Release Oral Tablet	PSN	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
830879	dilTIAZem hydrochloride 240 MG 24HR Extended Release Oral Tablet	PSN	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
830882	dilTIAZem hydrochloride 300 MG 24HR Extended Release Oral Tablet	PSN	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
830897	dilTIAZem hydrochloride 360 MG 24HR Extended Release Oral Tablet	PSN	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
830900	dilTIAZem hydrochloride 420 MG 24HR Extended Release Oral Tablet	PSN	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091632	Matzim LA 180 MG 24HR Extended Release Oral Tablet	PSN	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091629	Matzim LA 240 MG 24HR Extended Release Oral Tablet	PSN	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091635	Matzim LA 300 MG 24HR Extended Release Oral Tablet	PSN	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091638	Matzim LA 360 MG 24HR Extended Release Oral Tablet	PSN	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091623	Matzim LA 420 MG 24HR Extended Release Oral Tablet	PSN	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091632	24 HR diltiazem hydrochloride 180 MG Extended Release Oral Tablet [Matzim]	SBD	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091629	24 HR diltiazem hydrochloride 240 MG Extended Release Oral Tablet [Matzim]	SBD	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091635	24 HR diltiazem hydrochloride 300 MG Extended Release Oral Tablet [Matzim]	SBD	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091638	24 HR diltiazem hydrochloride 360 MG Extended Release Oral Tablet [Matzim]	SBD	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091623	24 HR diltiazem hydrochloride 420 MG Extended Release Oral Tablet [Matzim]	SBD	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
830877	24 HR diltiazem hydrochloride 180 MG Extended Release Oral Tablet	SCD	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
830879	24 HR diltiazem hydrochloride 240 MG Extended Release Oral Tablet	SCD	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
830882	24 HR diltiazem hydrochloride 300 MG Extended Release Oral Tablet	SCD	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
830897	24 HR diltiazem hydrochloride 360 MG Extended Release Oral Tablet	SCD	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
830900	24 HR diltiazem hydrochloride 420 MG Extended Release Oral Tablet	SCD	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091632	24 HR Matzim 180 MG Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091629	24 HR Matzim 240 MG Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091635	24 HR Matzim 300 MG Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091638	24 HR Matzim 360 MG Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091623	24 HR Matzim 420 MG Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
830877	diltiazem hydrochloride 180 MG 24 HR Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
830879	diltiazem hydrochloride 240 MG 24 HR Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
830882	diltiazem hydrochloride 300 MG 24 HR Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
830897	diltiazem hydrochloride 360 MG 24 HR Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
830900	diltiazem hydrochloride 420 MG 24 HR Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091632	Matzim LA 180 MG 24 HR Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091629	Matzim LA 240 MG 24 HR Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091635	Matzim LA 300 MG 24 HR Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091638	Matzim LA 360 MG 24 HR Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13
1091623	Matzim LA 420 MG 24 HR Extended Release Oral Tablet	SY	e8c8dd18-9d95-4068-9762-bec1eb1bc25c	13

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
52544-692-19	52544069219	90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52544-692-19)	2011-03-28	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Matzim LA	Actavis Pharma, Inc.	2025-05-01	HUMAN PRESCRIPTION DRUG LABEL	14
Matzim LA	REMEDYREPACK INC.	2019-08-19	HUMAN PRESCRIPTION DRUG LABEL	1